Paper Details 
Original Abstract of the Article :
OBJECTIVE: This study aims to analysis adverse drug events (ADE) related to Brexpiprazole from the third quarter of 2015 to the first quarter of 2023 from FAERS database. METHODS: The ADE data related to Brexpiprazole from 2015 Q3 to 2023 Q1 were collected. After standardizing the data, a variety o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jad.2023.11.025

データ提供:米国国立医学図書館(NLM)

A Comprehensive Safety Assessment of Brexpiprazole

This research takes a deep dive into the safety profile of [Brexpiprazole], a medication used to treat certain mental health conditions. The study analyzed data from the [FAERS database] to identify potential [adverse drug events (ADE)] associated with this drug.

Brexpiprazole’s Potential Side Effects

The analysis revealed a wide range of potential side effects, including [metabolism and nutrition disorders], [reproductive system and breast disorders], [egocentrism], [pharmacophobia], and [compulsions]. The study also highlighted the potential for [tardive dyskinesia] and [extrapyramidal disorder] – serious movement disorders.

Navigating the Complexities of Medication

Just like the intricate network of sand dunes in a desert, the potential effects of medications can be complex and multifaceted. This research serves as a valuable reminder of the importance of careful monitoring and understanding the potential risks associated with medications. It emphasizes the need for close collaboration between patients and healthcare providers to ensure safe and effective treatment.

Dr.Camel's Conclusion

This research reinforces the importance of vigilant monitoring when prescribing Brexpiprazole. Just as a camel navigates the treacherous desert, healthcare providers must navigate the complex terrain of potential side effects and strive to provide safe and effective treatment for their patients.
Date :
  1. Date Completed 2023-12-04
  2. Date Revised 2023-12-04
Further Info :

Pubmed ID

37956832

DOI: Digital Object Identifier

10.1016/j.jad.2023.11.025

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.